2 years ago

Advances in systemic therapy for advanced pancreatobiliary malignancies

Carcinomas of the biliary system are uncommon malignancies and Sunitinib usually unresectable at the time of diagnosis54. Given the rel read more...

2 years ago

Advances in systemic therapy for advanced pancreatobiliary malignancies

Pancreatobiliary malignancies are relatively uncommon malignancies that Sunitinib normally have a poor prognosis (Figure one). In 2012, almost 42,000 new situatio read more...

2 years ago

Advances in systemic therapy for advanced pancreatobiliary malignancies

Rodent glioma mobile line F98 and the human glioma mobile line U87 ended up Sunitinib acquired from ATCC (Wesel, Germany). Yvonne Rübn read more...